Countering the problem of falsified and substandard drugs:
Gespeichert in:
| Körperschaft: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Washington, District of Columbia
National Academies Press
[2013]
|
| Schlagworte: | |
| Beschreibung: | Includes bibliographical references |
| Beschreibung: | 1 Online-Ressource (375 pages) |
| ISBN: | 9780309269407 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV041956950 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 140707s2013 |||| o||u| ||||||eng d | ||
| 020 | |a 9780309269407 |c Online |9 978-0-309-26940-7 | ||
| 035 | |a (OCoLC)880439886 | ||
| 035 | |a (DE-599)BVBBV041956950 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 110 | 2 | |a Institute of Medicine (U.S.) |b Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Countering the problem of falsified and substandard drugs |c Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, Board on Global Health ; Gillian J. Buckley and Lawrence O. Gostin, editors ; Institute of Medicine of the National Academies |
| 264 | 1 | |a Washington, District of Columbia |b National Academies Press |c [2013] | |
| 300 | |a 1 Online-Ressource (375 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references | ||
| 650 | 4 | |a Pharmaceutical industry / Quality control | |
| 650 | 4 | |a Fraud / Prevention | |
| 653 | |a Electronic books | ||
| 700 | 1 | |a Buckley, Gillian J. |e Sonstige |4 oth | |
| 700 | 1 | |a Gostin, Lawrence O. |e Sonstige |4 oth | |
| 710 | 2 | |a Institute of Medicine |b Board on Global Health |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Paperback |z 0-309-26939-3 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Paperback |z 978-0-309-26939-1 |
| 912 | |a ZDB-38-EBR | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-027399838 | ||
Datensatz im Suchindex
| _version_ | 1804152340873216000 |
|---|---|
| any_adam_object | |
| author_corporate | Institute of Medicine (U.S.) Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products |
| author_corporate_role | aut |
| author_facet | Institute of Medicine (U.S.) Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products |
| author_sort | Institute of Medicine (U.S.) Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products |
| building | Verbundindex |
| bvnumber | BV041956950 |
| collection | ZDB-38-EBR |
| ctrlnum | (OCoLC)880439886 (DE-599)BVBBV041956950 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01689nmm a2200361zc 4500</leader><controlfield tag="001">BV041956950</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">140707s2013 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309269407</subfield><subfield code="c">Online</subfield><subfield code="9">978-0-309-26940-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)880439886</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV041956950</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="b">Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Countering the problem of falsified and substandard drugs</subfield><subfield code="c">Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, Board on Global Health ; Gillian J. Buckley and Lawrence O. Gostin, editors ; Institute of Medicine of the National Academies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, District of Columbia</subfield><subfield code="b">National Academies Press</subfield><subfield code="c">[2013]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (375 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry / Quality control</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Fraud / Prevention</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Electronic books</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Buckley, Gillian J.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gostin, Lawrence O.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine</subfield><subfield code="b">Board on Global Health</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Paperback</subfield><subfield code="z">0-309-26939-3</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Paperback</subfield><subfield code="z">978-0-309-26939-1</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-38-EBR</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-027399838</subfield></datafield></record></collection> |
| id | DE-604.BV041956950 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T01:09:10Z |
| institution | BVB |
| isbn | 9780309269407 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-027399838 |
| oclc_num | 880439886 |
| open_access_boolean | |
| physical | 1 Online-Ressource (375 pages) |
| psigel | ZDB-38-EBR |
| publishDate | 2013 |
| publishDateSearch | 2013 |
| publishDateSort | 2013 |
| publisher | National Academies Press |
| record_format | marc |
| spelling | Institute of Medicine (U.S.) Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products Verfasser aut Countering the problem of falsified and substandard drugs Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, Board on Global Health ; Gillian J. Buckley and Lawrence O. Gostin, editors ; Institute of Medicine of the National Academies Washington, District of Columbia National Academies Press [2013] 1 Online-Ressource (375 pages) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references Pharmaceutical industry / Quality control Fraud / Prevention Electronic books Buckley, Gillian J. Sonstige oth Gostin, Lawrence O. Sonstige oth Institute of Medicine Board on Global Health Sonstige oth Erscheint auch als Druck-Ausgabe, Paperback 0-309-26939-3 Erscheint auch als Druck-Ausgabe, Paperback 978-0-309-26939-1 |
| spellingShingle | Countering the problem of falsified and substandard drugs Pharmaceutical industry / Quality control Fraud / Prevention |
| title | Countering the problem of falsified and substandard drugs |
| title_auth | Countering the problem of falsified and substandard drugs |
| title_exact_search | Countering the problem of falsified and substandard drugs |
| title_full | Countering the problem of falsified and substandard drugs Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, Board on Global Health ; Gillian J. Buckley and Lawrence O. Gostin, editors ; Institute of Medicine of the National Academies |
| title_fullStr | Countering the problem of falsified and substandard drugs Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, Board on Global Health ; Gillian J. Buckley and Lawrence O. Gostin, editors ; Institute of Medicine of the National Academies |
| title_full_unstemmed | Countering the problem of falsified and substandard drugs Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, Board on Global Health ; Gillian J. Buckley and Lawrence O. Gostin, editors ; Institute of Medicine of the National Academies |
| title_short | Countering the problem of falsified and substandard drugs |
| title_sort | countering the problem of falsified and substandard drugs |
| topic | Pharmaceutical industry / Quality control Fraud / Prevention |
| topic_facet | Pharmaceutical industry / Quality control Fraud / Prevention |
| work_keys_str_mv | AT instituteofmedicineuscommitteeonunderstandingtheglobalpublichealthimplicationsofsubstandardfalsifiedandcounterfeitmedicalproducts counteringtheproblemoffalsifiedandsubstandarddrugs AT buckleygillianj counteringtheproblemoffalsifiedandsubstandarddrugs AT gostinlawrenceo counteringtheproblemoffalsifiedandsubstandarddrugs AT instituteofmedicineboardonglobalhealth counteringtheproblemoffalsifiedandsubstandarddrugs |